Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Lane, Melanie"'
Autor:
Becskei, Csilla, De Bock, Filip, Illambas, Joanna, Cherni, Judith A., Fourie, Josephus J., Lane, Melanie, Mahabir, Sean P., Six, Robert H.
Publikováno v:
In Veterinary Parasitology 30 May 2016 222:56-61
Autor:
Wang Amy T, Mullan Rebecca J, Lane Melanie A, Hazem Ahmad, Prasad Chaithra, Gathaiya Nicola W, Fernández-Balsells M, Bagatto Amy, Coto-Yglesias Fernando, Carey Jantey, Elraiyah Tarig A, Erwin Patricia J, Gandhi Gunjan Y, Montori Victor M, Murad Mohammad
Publikováno v:
Systematic Reviews, Vol 1, Iss 1, p 33 (2012)
Abstract Background Hyperprolactinemia is a common endocrine disorder that can be associated with significant morbidity. We conducted a systematic review and meta-analyses of outcomes of hyperprolactinemic patients, including microadenomas and macroa
Externí odkaz:
https://doaj.org/article/f057892924cc447ea41b0b91e720c0a0
Autor:
Murad M Hassan, Hazem Ahmad, Coto-Yglesias Fernando, Dzyubak Svitlana, Gupta Shabnum, Bancos Irina, Lane Melanie A, Erwin Patricia J, Berglund Lars, Elraiyah Tarig, Montori Victor M
Publikováno v:
BMC Endocrine Disorders, Vol 12, Iss 1, p 2 (2012)
Abstract Background Hypertriglyceridemia may be associated with important complications. The aim of this study is to estimate the magnitude of association and quality of supporting evidence linking hypertriglyceridemia to cardiovascular events and pa
Externí odkaz:
https://doaj.org/article/869ef4179590493c901fb3b02a66d386
Autor:
Tilburt Jon C, James Katherine M, Sinicrope Pamela S, Eton David T, Costello Brian A, Carey Jantey, Lane Melanie A, Ehlers Shawna L, Erwin Patricia J, Nowakowski Katherine E, Murad Mohammad H
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 9, Iss 1, p 2 (2011)
Abstract Background Patients at higher than average risk of heritable cancer may process risk information differently than the general population. However, little is known about clinical, demographic, or psychosocial predictors that may impact risk p
Externí odkaz:
https://doaj.org/article/00b79f4434ef48af87b86a8c77c83a75
Autor:
Mullan Rebecca J, Bankhead Clare R, Kaur Jagdeep, Sood Amit, Raatz Heike, Mulla Sohail M, Burns Karen EA, Nordmann Alain J, Lampropulos Julianna F, Bucher Heiner C, Karanicolas Paul J, You John J, Elnour Nisrin, Soares Heloisa P, Kirpalani Haresh, Gwadry-Sridhar Femida, Mills Edward J, Adhikari Neill KJ, Djulbegovic Benjamin, Murad M Hassan, Strahm Brigitte, Elamin Mohamed B, Flynn David N, da Silva Suzana, Culebro Carolina, Kunz Regina, Urrutia Gerard, Alonso-Coello Pablo, Ferreira-Gonzalez Ignacio, Akl Elie A, Malaga German, Glasziou Paul, Bassler Dirk, Montori Victor M, Lane Melanie, Briel Matthias, Nerenberg Kara A, Vandvik Per, Coto-Yglesias Fernando, Schünemann Holger, Tuche Fabio, Chrispim Pedro, Cook Deborah J, Lutz Kristina, Ribic Christine M, Vale Noah, Erwin Patricia J, Perera Rafael, Zhou Qi, Heels-Ansdell Diane, Ramsay Tim, Walter Stephen D, Guyatt Gordon H
Publikováno v:
Trials, Vol 10, Iss 1, p 49 (2009)
Abstract Background Randomized clinical trials (RCTs) stopped early for benefit often receive great attention and affect clinical practice, but pose interpretational challenges for clinicians, researchers, and policy makers. Because the decision to s
Externí odkaz:
https://doaj.org/article/e1148e1197a4473dbfb3d71c3d7b03e2